For the new Dual Protect to become the product of choice its imperative that any myths or negatives are dispelled.
Reading over the comments section from my previous attachment, I noticed a number of people commenting (below the article). Some had labels such as professor, medical analyst and one was a member of a HIV organization. For the Dual Protect to be a great success I would think it needs to win over the main players such as these groups.
I went looking for actual studies and located this article, which lists a study in the USA of the gel. Reassuringly, the company replied to the findings (see below).
http://www.huffingtonpost.com/2014/07/24/vivagel-condom_n_5617600.html
For the new Dual Protect to become the product of choice its...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |